Presbyopia is treated by a method which uses ablative lasers to ablate the sclera tissue and increase the accommodation of the ciliary body. tissue bleeding is prevented by an ablative laser having a wavelength of between 0.15 and 3.2 micron. A scanning system is proposed to perform various patterns on the sclera area of the cornea to treat presbyopia and to prevent other eye disorder such as glaucoma. laser parameters are determined for accurate sclera expansion.
REEXAMINATION RESULTS
The questions raised in reexamination request no. 90/006,090, filed Aug. 22, 2001, have been considered and the results thereof are reflected in this reissue patent which constitutes the reexamination certificate required by 35 U.S.C. 307 as provided in 37 CFR 1.570(e), for ex parte reexaminations, or the reexamination certificate required by 35 U.S.C. 316 as provided in 37 CFR 1.997(e) for inter partes reexaminations.
|
0. 14. A method of improving accommodation and/or treating presbyopia, comprising:
cutting at least three spaced apart, substantially radial lines in the scleral tissue of a patient's eye outside the limbus to a depth of 80-90% of the thickness of the scleral tissue.
1. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera comprising the steps of:
selecting a pulsed ablation laser having a pulsed output beam of predetermined wavelength;
selecting a beam spot controller mechanism for reducing and focusing said selected ablative laser's output beam onto a predetermined spot size on the surface of the cornea eye;
selecting a scanning mechanism for scanning said ablative laser output beam;
coupling said ablative laser beam to a scanning device for scanning said ablative laser over a predetermined area of the corneal sclera; and
controlling said scanning mechanism to deliver said ablative laser beam in a predetermined pattern in said predetermined area onto the surface of the cornea eye to photoablate the sclera tissue outside the limbus to a depth of 80-90% of the thickness of the scleral tissue, whereby a presbyopic patient's vision is corrected by expansion of the sclera.
2. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
3. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
4. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
5. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with claim 1 in which the step of selecting a pulsed ablation laser includes selecting a pulsed gas laser having a pulse duration shorter than 200 nanoseconds.
6. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
7. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
8. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
9. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by an ablating laser beam in accordance with
10. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
11. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
selecting a metal mask having at least one slit therein; and
positioning the selected mask over the cornea eye surface for scanning the ablation laser thereover for controlling the ablation slit pattern on the sclera tissue outside the limbus.
12. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
13. A laser beam ophthalmological surgery method for treating presbyopic presbyopia in a patient's eye by ablating the sclera in accordance with
0. 15. A method as in
0. 16. A method as in
0. 17. A method as in
0. 18. A method as in
0. 19. A method as in
0. 20. A method as in
0. 21. A method as in
0. 22. A method as in
0. 23. A method as in
|
1. Field of the Invention
The present invention relates to methods and apparatus for the treatment of presbyopia and the treatment and prevention of glaucoma using dual-beam scanning lasers.
2. Prior Art
Corneal reshaping, including a procedure called photorefractive keratectomy (PRK) and a new procedure called laser assisted in situ keratomileusis, or laser intrastroma keratomileusis (LASIK), has been performed by lasers in the ultraviolet (UV) wavelength of 193-213 nm. Commercial UV refractive lasers include ArF excimer lasers at 193 nm and other non-excimer, solid-state lasers, such as the one patented by the present inventor in 1992 (U.S. Pat. No. 5,144,630). Precise, stable corneal reshaping requires lasers with strong tissue absorption (or minimum penetration depth) such that the thermal damage zone is at a minimum (less than few microns). Furthermore, accuracy of the procedure of vision correction depends on the amount of tissue removed in each laser pulse, in the order of about 0.2 microns. Therefore, lasers at UV wavelengths between 193 and 213 nm and at the mid-infrared wavelengths between 2.8 and 3.2 microns are two attractive wavelength ranges which match the absorption peak of protein and water, respectively.
The above-described prior arts are however limited to the use of reshaping the corneal surface curvature for the correction of myopia and hyperopia. A variation of farsightedness that the existing laser surgery procedures will not treat is presbyopia, and the gradual age related condition of suddenly fuzzy print and the necessity of reading glasses. When a person reaches a certain age (around 40), the eyes start to lose their capability to focus sharply for near vision. Presbyopia is not due to the cornea but comes about as the lens loses its ability to accommodate or focus sharply for near vision as a result of loss of elasticity that is inevitable as people age.
Thermal lasers such as Ho:YAG have been proposed for the correction of hyperopia by laser-induced coagulation of the corneal. The present inventor has also proposed the use of a laser-generated bifocal for the treatment of presbyopic patients but fundamental issues caused by age of presbyopic patients still remains unsolved in those prior approaches.
To treat presbyopic patients, or the reversal of presbyopia, using the concept of expanding the sclera by mechanical devices has been proposed by Schaker in U.S. Pat. Nos. 5,529,076, 5,722,952, 5,465,737 and 5,354,331. These mechanical approaches have the drawbacks of complexity and are time consuming, costly and have potential side effects. To treat presbyopia, the Schaker U.S. Pat. Nos. 5,529,076 and 5,722,952 propose the use of heat or radiation on the corneal epithelium to arrest the growth of the crystalline lens and also propose the use of lasers to ablate portions of the thickness of the sclera. However, these prior arts do not present any details or practical methods or laser parameters for the presbyopic corrections. No clinical studies have been practiced to show the effectiveness of the proposed concepts. The concepts proposed in the Schaker patents regarding lasers suitable for expanding the sclera tissues were incorrect in that the proposed lasers did not identify those which are “cold lasers” and can only conduct the tissue ablation rather than thermal burning of the cornea. Furthermore, the clinical issues, such as accuracy of the sclera tissue removal and potential tissue bleeding during the procedures, were not indicated in these prior patents. In addition, it is essential to use a scanning laser to achieve the desired ablation pattern and to control the ablation depth on the sclera tissue.
One objective of the present invention is to provide an apparatus and method to obviate these drawbacks in the above Schaker patents.
It is yet another objective of the present invention to provide an apparatus and method which provide the well-defined laser parameters for efficient and accurate sclera expansion for presbyopia reversal and the treatment and preventing of open angle glaucoma.
It is yet another objective of the present invention to use a scanning device such that the degree of ciliary muscle accommodation can be controlled by the location, size and shapes of the removed sclera tissue.
It is yet another objective of the present invention to define the non-thermal lasers for efficient tissue ablation and thermal lasers for tissue coagulation. This system is able to perform both in an ablation mode and in a coagulation mode for optimum clinical outcomes. It is yet another objective of the present invention to provide an integrated system in which dual-beam lasers can be scanned over the corneal surface for accurate ablation of the sclera tissue without bleeding, with ablation and coagulation laser beams simultaneously applied on the cornea.
It is yet another objective of the present invention to define the optimal laser parameters and the ablation patterns for best clinical outcome for presbyopia patients, where sclera expansion will increase the accommodation of the ciliary muscle.
It is yet another objective of the present invention to provide the appropriate scanning patterns which will cause effective sclera expansion.
The preferred embodiments of the present surgical laser consists of a combination of an ablative-type laser and a coagulative-type laser. The ablative-type laser has a wavelength range of from 0.15 to 0.35 microns and from 2.6 to 3.2 microns and is operated in a Q-switch mode such that the thermal damage of the corneal tissue is minimized. The coagulative-type lasers includes a thermal laser having a wavelength of between 0.45 and 0.9 microns and between 1.5 and 3.2 microns, and between 9 and 12 microns operated at a long-pulse or continuous-wave mode.
It is yet another preferred embodiment of the present invention to provide a scanning mechanism to effectively ablate the sclera tissue at a controlled depth by beam overlapping.
It is yet another preferred embodiments of the present invention to provide an apparatus and method such that both the ablative and the coagulative lasers can have applied to their beams the corneal surface to thereby prevent bleeding during the procedure.
It is yet another embodiment of the present invention to provide an integration system in which a coagulative laser may have the beam delivered by a scan or by a fiber-coupled device which can be manually scanned over the cornea. It is yet another embodiment of the present invention to focus the laser beams in a small circular spot or a line pattern.
It is yet another embodiment of the present invention to provide a coagulative laser to prevent the sclera tissue bleeding when a diamond knife is used for the incision of the sclera.
It is yet another embodiment of the present invention to use a metal mask on the corneal surface to generate a small slit when the laser is scanning over the mask. In this embodiment, the exact laser spot size and its propagating stability are not critical.
It is yet another embodiment of the present invention to provide an integration system in which the sclera expansion leads to the increase of the accommodation of the ciliary muscle for the treatment of presbyopia and the prevention of open angle glaucoma.
Further preferred embodiments of the present invention will become apparent from the description of the invention which follows.
Referring to
Another embodiment of controlling the ablation area of the sclera area is to use a metal mask which has a plurality of slits each having an approximate dimension of 0.1-0.3 mm×3.0-5.0 mm. Both of the ablative and coagulative lasers will scan over the mask which is placed on the corneal surface to generate the desired slit pattern on the sclera. In this embodiment using a mask, the small laser spot sizes of 0.1 mm, which may be difficult to achieve, are not needed in order to generate the slit size on the cornea. Laser spot sizes of 0.2-1.0 mm will generate the desired ablation dimension on the sclera after scanning over the mask. Furthermore, the embodiment of using a mask will not require a precise stability of the laser beam path onto the corneal surface. Without using a mask, both the exact laser beam spot size and its stability in propagating would be essential.
Another embodiment of sclera expansion of the present invention is to use diamond knife for the incision of the sclera tissue in the patterns described in
The invention having now been fully described, it should be understood that it may be embodied in other specific forms or variations without departing from the spirit or essential characteristics of the present invention. Accordingly, the embodiments described herein are to be considered to be illustrative and not restrictive.
Patent | Priority | Assignee | Title |
10463541, | Mar 25 2011 | LENSAR, INC | System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions |
10842675, | Jan 20 2006 | LENSAR, INC | System and method for treating the structure of the human lens with a laser |
8262646, | Jan 20 2006 | LENSAR, INC | System and method for providing the shaped structural weakening of the human lens with a laser |
8382745, | Jul 24 2009 | LENSAR, INC | Laser system and method for astigmatic corrections in association with cataract treatment |
8465478, | Jul 24 2009 | LENSAR, INC | System and method for performing LADAR assisted procedures on the lens of an eye |
8480659, | Jul 25 2008 | LENSAR, INC | Method and system for removal and replacement of lens material from the lens of an eye |
8500723, | Jul 25 2008 | LENSAR, INC | Liquid filled index matching device for ophthalmic laser procedures |
8556425, | Feb 01 2010 | LENSAR, INC | Purkinjie image-based alignment of suction ring in ophthalmic applications |
8617146, | Jul 24 2009 | LENSAR, INC | Laser system and method for correction of induced astigmatism |
8708491, | Jul 25 2008 | LENSAR, INC | Method and system for measuring an eye |
8758332, | Jul 24 2009 | LENSAR, INC | Laser system and method for performing and sealing corneal incisions in the eye |
8801186, | Oct 15 2010 | LENSAR, INC | System and method of scan controlled illumination of structures within an eye |
9180051, | Jan 20 2006 | LENSAR, INC | System and apparatus for treating the lens of an eye |
9375349, | Jan 20 2006 | LENSAR, INC | System and method for providing laser shot patterns to the lens of an eye |
9545338, | Jan 20 2006 | LENSAR, INC | System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser |
9889043, | Jan 20 2006 | LENSAR, INC | System and apparatus for delivering a laser beam to the lens of an eye |
D694890, | Oct 15 2010 | LENSAR, INC | Laser system for treatment of the eye |
D695408, | Oct 15 2010 | LENSAR, INC | Laser system for treatment of the eye |
RE46493, | Jun 01 2000 | The General Hospital Corporation | Selective photocoagulation |
Patent | Priority | Assignee | Title |
4592065, | Jun 25 1982 | COMPAGNIE INDUSTRIELLE DES LASERS CILAS ALCATEL ROUTE DENOZAY | Gas laser excited by a transverse electrical discharge triggered by photoionization |
4755999, | Mar 25 1985 | MACKEN LASER, INC A CA CORPORATION | Laser apparatus utilizing a magnetically enhanced electrical discharge |
4773414, | Nov 17 1983 | Visx, Incorporated | Method of laser-sculpture of the optically used portion of the cornea |
4846172, | May 26 1987 | Laser-delivery eye-treatment method | |
4907586, | Mar 31 1988 | AMO Development, LLC | Method for reshaping the eye |
5019074, | Mar 09 1987 | Summit Technology, Inc.; SUMMIT TECHNOLOGY, INC | Laser reprofiling system employing an erodable mask |
5102409, | Apr 22 1988 | BMB Patent Holding Corporation | Method and apparatus for modification of corneal refractive properties |
5108388, | Dec 15 1983 | AMO Manufacturing USA, LLC | Laser surgery method |
5144630, | Jul 29 1991 | General Electric Capital Corporation | Multiwavelength solid state laser using frequency conversion techniques |
5152760, | Mar 17 1989 | The General Hospital Corporation | Non-invasive sclerostomy |
5163934, | Aug 05 1987 | AMO Manufacturing USA, LLC | Photorefractive keratectomy |
5354331, | Jul 15 1992 | REFOCUS OCULAR, INC | Treatment of presbyopia and other eye disorders |
5423801, | Jun 02 1986 | Summit Technology, Inc. | Laser corneal surgery |
5465737, | Oct 22 1993 | REFOCUS OCULAR, INC | Treatment of presbyopia and other eye disorders |
5484432, | Sep 27 1985 | RJW ACQUISTIONS, L C , D B A 20 20 TECHNOLOGIES, INC | Collagen treatment apparatus |
5490849, | Jul 13 1990 | Uniform-radiation caustic surface for photoablation | |
5520679, | Dec 03 1992 | General Electric Capital Corporation | Ophthalmic surgery method using non-contact scanning laser |
5529076, | Jul 15 1992 | REFOCUS OCULAR, INC | Treatment of presbyopia and other eye disorders |
5533997, | Jun 29 1994 | Apparatus and method for performing presbyopia corrective surgery | |
5549598, | May 22 1995 | Glaucoma laser trabeculodissection | |
5599341, | Jun 15 1994 | ADDITION TECHNOLOGY, INC | Laser surgical procedure and device for treatment of the cornea |
5630810, | May 06 1994 | General Electric Capital Corporation | Method of ophthalmological surgery |
5722952, | Jul 15 1992 | REFOCUS OCULAR, INC | Treatment of presbyopia and other eye disorders |
5738676, | Jan 03 1995 | UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | Laser surgical probe for use in intraocular surgery |
5741247, | Aug 31 1995 | BIOLASE, INC | Atomized fluid particles for electromagnetically induced cutting |
5782822, | Oct 27 1995 | AMO Manufacturing USA, LLC | Method and apparatus for removing corneal tissue with infrared laser radiation |
5803923, | Sep 15 1994 | Jugvir I., Singh-Derewa | Presbyopia correction using a protected space pattern, methods and apparatus |
5845024, | Sep 16 1994 | Namiki Precision Jewel Co., Ltd. | Optical fiber with lens and method of manufacturing the same |
5891131, | Feb 01 1993 | Arizona Board of Regents | Method and apparatus for automated simulation and design of corneal refractive procedures |
5928129, | Jun 29 1994 | Apparatus and method for performing presbyopia corrective surgery | |
5984916, | Apr 20 1993 | AMO Development, LLC | Ophthalmic surgical laser and method |
5997529, | Oct 28 1996 | General Electric Capital Corporation | Compound astigmatic myopia or hyperopia correction by laser ablation |
6010497, | Jan 07 1998 | General Electric Capital Corporation | Method and apparatus for controlling scanning of an ablating laser beam |
6019754, | Oct 29 1998 | Method and apparatus for improving lasik flap adherence | |
6090100, | Oct 01 1992 | Technolas GmbH Ophthalmologische Systeme | Excimer laser system for correction of vision with reduced thermal effects |
6090102, | May 12 1997 | AMO Manufacturing USA, LLC | Short pulse mid-infrared laser source for surgery |
6099522, | Feb 06 1989 | AMO Manufacturing USA, LLC | Automated laser workstation for high precision surgical and industrial interventions |
6132424, | Mar 13 1998 | General Electric Capital Corporation | Smooth and uniform laser ablation apparatus and method |
6156030, | Jun 04 1997 | Y-BEAM TECHNOLOGIES, INC | Method and apparatus for high precision variable rate material removal and modification |
6161546, | Jul 17 1995 | UNIVERSITY OF ILLINOIS, BOARD OF TRUSTESS, THE | System for altering tissue beneath an outer layer of tissue |
6171336, | Mar 26 1996 | Method, implant, and apparatus for refractive keratoplasty | |
6190374, | Nov 29 1996 | Nidek Co., Ltd. | Apparatus for operating upon a cornea |
6197018, | Aug 12 1996 | Laser method for restoring accommodative potential | |
6197056, | Jul 15 1992 | REFOCUS OCULAR, INC | Segmented scleral band for treatment of presbyopia and other eye disorders |
6203538, | Sep 29 1997 | HEALTHCARE ROYALTY PARTNERS II, L P | Intrastromal corneal modification |
6210401, | Aug 02 1991 | Method of, and apparatus for, surgery of the cornea | |
6258082, | May 03 1999 | NEOS OCULAR, INC | Refractive surgery and presbyopia correction using infrared and ultraviolet lasers |
6263879, | Nov 10 1998 | NEOS OCULAR, INC | Treatment of presbyopia and other eye disorders using a scanning laser system |
6280435, | Mar 04 1998 | AMO Manufacturing USA, LLC | Method and systems for laser treatment of presbyopia using offset imaging |
6364871, | Oct 21 1996 | Apollo Vision, Inc. | Method and device for sculpturing laser beams |
6745775, | Nov 10 1998 | NEOS OCULAR, INC | Methods and apparatus for presbyopia treatment using a scanning laser system |
6824540, | Nov 06 2000 | NEOS OCULAR, INC | Apparatus and methods for the treatment of presbyopia using fiber-coupled-lasers |
20010029363, | |||
20030220630, | |||
WO9841177, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 24 2003 | SurgiLight, Inc. | (assignment on the face of the patent) | / | |||
Oct 27 2004 | SURGILIGHT, INC | KNOBBE, MARTENS, OLSON & BEAR, LLP | SECURITY INTEREST | 016127 | /0885 | |
Apr 16 2007 | SURGILIGHT, INC | GEM SURGILIGHT INVESTORS, LLC | SECURITY AGREEMENT | 019628 | /0717 |
Date | Maintenance Fee Events |
Feb 02 2009 | REM: Maintenance Fee Reminder Mailed. |
Jul 09 2009 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Jul 09 2009 | M2555: 7.5 yr surcharge - late pmt w/in 6 mo, Small Entity. |
Mar 04 2013 | REM: Maintenance Fee Reminder Mailed. |
Jul 24 2013 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Jan 15 2011 | 4 years fee payment window open |
Jul 15 2011 | 6 months grace period start (w surcharge) |
Jan 15 2012 | patent expiry (for year 4) |
Jan 15 2014 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jan 15 2015 | 8 years fee payment window open |
Jul 15 2015 | 6 months grace period start (w surcharge) |
Jan 15 2016 | patent expiry (for year 8) |
Jan 15 2018 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jan 15 2019 | 12 years fee payment window open |
Jul 15 2019 | 6 months grace period start (w surcharge) |
Jan 15 2020 | patent expiry (for year 12) |
Jan 15 2022 | 2 years to revive unintentionally abandoned end. (for year 12) |